U.S., April 30 -- An application to own the trademark for 'REHALYNZ' has been filed on Dec. 10, 2024.
Owner(s):
Genentech, Inc.; 1 DNA Way, , California
Goods and/or Services:
For: Pharmaceutical preparations for the treatment of metabolic diseases and disorders, Pharmaceutical preparations for the treatment of cardio-vascular diseases and disorders; Pharmaceutical preparations for use in immunology; Pharmaceutical preparations for the treatment of renal disorders
Class(es): 005, 006, 018, 044, 046, 051, 052
Mark Drawing Type: 4 - STANDARD CHARACTER MARK
https://eog-tmng.uspto.gov/#/issueDate=2025-04-29&serialNumber=98895052
Disclaimer: Curated by HT Syndication....